Cargando…
Structural Basis for How Biologic Medicines Bind their Targets in Psoriasis Therapy
As biologic therapies become first line treatments for many inflammatory disorders, it becomes increasingly important for the practicing physician to be familiar with how these drugs function at the molecular level. This information is useful in making therapeutic decisions and helping patients unde...
Autores principales: | Eldirany, Sherif A., Ho, Minh, Bunick, Christopher G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
YJBM
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087057/ https://www.ncbi.nlm.nih.gov/pubmed/32226331 |
Ejemplares similares
-
Structural basis for differential p19 targeting by IL-23 biologics
por: Daniele, Stefano G., et al.
Publicado: (2023) -
Crystal Structure of Keratin 1/10(C401A) 2B Heterodimer Demonstrates a Proclivity for the C-Terminus of Helix 2B to Form Higher Order Molecular Contacts
por: Lomakin, Ivan B., et al.
Publicado: (2020) -
Molecular Modeling of Pathogenic Mutations in the Keratin 1B Domain
por: Hinbest, Alexander J., et al.
Publicado: (2020) -
Ixekizumab-induced alopecia areata
por: Eldirany, Sherif A., et al.
Publicado: (2019) -
Dermatomyositis associated with an adrenal adenoma
por: Eldirany, Sherif A., et al.
Publicado: (2021)